PF-08046032

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-08046032, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers [Phase 1]